Good manufacturing practices guide for drug products

dc.date.accessioned 2021-08-24T19:32:56Z
dc.date.available 2021-08-24T19:32:56Z
dc.date.issued 2018-02-28
dc.description These guidelines interpret the requirements for good manufacturing practices (GMP) in Part C, Division 2 of the Regulations. They were developed by Health Canada in consultation with stakeholders.
dc.description.abstract These guidelines interpret the requirements for good manufacturing practices (GMP) in Part C, Division 2 of the Regulations. They were developed by Health Canada in consultation with stakeholders.
dc.ejemplo3.0.ejem Health Canada
dc.identifier.uri https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/gui-0001-fr.pdf
dc.identifier.uri https://demo7.dspace.org/handle/10673/2953
dc.language.iso fr
dc.publisher Health Canada
dc.title Good manufacturing practices guide for drug products
dc.type Article
myns.contributor.2ndlang Santé Canada fr
myns.description.2ndlang Ces lignes directrices décrivent les exigences des Bonnes pratiques de fabrication (BPF) dans la Partie C, Titre 2 du Règlement. Elles ont été élaborées par Santé Canada avec le concours d’intervenants. fr
myns.publisher.2ndlang Santé Canada fr
myns.title.2ndlang Lignes directrices sur les Bonnes pratiques de fabrication des drogues fr
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
gui-0001-fr.pdf
Size:
1.23 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections